XFOR X4 Pharmaceuticals Inc. Net earnings per share growth forecast for next year
High R&D costs and a small patient pool are squeezing margins, which is reflected in the net income per share growth projection for n+1. However, the stability of X4 Pharmaceuticals is based on the long-term treatment of chronic pathologies and physician trust in their unique hematopoiesis agents. The value of -21.70 expresses the latest metric level, capturing current analyst expectations for business profitability.
Analytical breakdowns for X4 Pharmaceuticals
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity Ratio X4 Pharmaceuticals|XFOR - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital X4 Pharmaceuticals, Inc.|XFOR - Company Debts|Debts to Book Capitalization Ratio X4 Pharmaceuticals|XFOR - Company Long-Term Debts|Company Short-Term Loans and Borrowings X4 Pharmaceuticals|Quick Ratio x4pharma.com
- earnings and valuation multiples information:
XFOR - Company Net Income|Expected Net Income X4 Pharmaceuticals|XFOR - Price to Earnings Ratio|Projected Price to Earnings X4 Pharmaceuticals|XFOR - PEG Multiple|EV/EBITDA Multiple X4 Pharmaceuticals|XFOR - Operating profit EBITDA|Net earnings per share for the last 12 months X4 Pharmaceuticals|XFOR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months x4pharma.com|XFOR - Net earnings per share growth this year|Earnings growth forecast for next year X4 Pharmaceuticals
Summary company analysis:XFOR (X4 Pharma)
As a portfolio manager, I view this indicator as a leading marker of market expectations. The one-year forward EPS growth rate measures the percentage change in expected earnings per share, reflecting the valuation's sensitivity to future cash flows. For X4 Pharmaceuticals (XFOR), the trend of this metric depends directly on the efficiency of pharmaceutical logistics and the stability of rare drug supplies.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA: Expected earnings per share growth for next year|GRFS (Grifols Biemat) - Projected earnings per share growth rate for next year|Projected earnings per share growth rate for next year Adaptive Biotechnologies|Expected earnings per share growth for next year celldex.com|AUPH - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BCRX|VERA - Net earnings per share change forecast for next year|Earnings growth forecast for next year Dianthus Corp (DNTH)|Expected earnings per share trend next year Pharvaris N.V.|Earnings growth forecast for next year abcellera.com ABCL|Tourmaline Bio - Earnings growth forecast for next year|PGEN: Net earnings per share growth forecast for next year|Expected earnings per share trend next year Pharming PHAR|NKTR (Nektar Corp) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year UPB|Earnings growth forecast for next year zenasbio.com|Earnings growth forecast for next year IMNM|Earnings growth forecast for next year Gossamer Bio Inc (GOSS)|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Septerna Pharma SEPN|PVLA (Pieris Pharmaceuticals) - Expected net earnings per share growth next year|savarapharma.com (SVRA) - Expected earnings per share growth for next year|RIGL: Earnings growth forecast for next year|Expected earnings per share growth for next year AnaptysBio Inc|Astria Pharma (ATXS) - Projected earnings per share increase next year|Earnings growth forecast for next year enGene Corp|RAPT (RAPT Therapeutics, Inc.) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year aerovatetx.com (JBIO)|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences PLC - Earnings growth forecast for next year|CABA: Net earnings per share growth forecast for next year|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|THTX (theratech.com) - Net earnings per share growth forecast for next year|AVTX: Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year Eledon Pharmaceuticals Inc. (ELDN)|Projected earnings per share growth rate for next year Agenus Inc AGEN|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Zura Bio Limited (ZURA) - Net earnings per share change forecast for next year|atyrpharma.com - Net earnings per share growth forecast for next year|ADAG (Adagene Corp) - Expected net earnings per share growth next year|IMA: Net earnings per share growth forecast for next year|Expected earnings per share trend next year shattucklabs.com STTK|EQ (Equillium) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year Connect Biopharma Holdings CNTB|Earnings growth forecast for next year Immunic Inc|Atara Biotherapeutics (ATRA) - Expected earnings per share trend next year|Earnings growth forecast for next year inflarx.de (IFRX)|Earnings growth forecast for next year ACET (Adicet Bio, Inc.)|Celularity Inc - Net earnings per share growth forecast for next year|Expected earnings per share trend next year INmune Bio, Inc. (INMB)|BRNS: Net earnings per share growth forecast for next year|KZR (Kezar Life Sciences, Inc.) - Expected earnings per share growth for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|AKTX (Akari Therapeutics plc) - Earnings growth forecast for next year|Expected earnings per share growth for next year Enlivex Therapeutics, Ltd. (ENLV)|Q32 Bio Inc. (QTTB) - Expected earnings per share trend next year|Earnings growth forecast for next year geovax.com (GOVX)|Consensus forecast of earnings per share growth for next year EDSA|iBio Inc - Net earnings per share growth forecast for next year|CARM: Expected earnings per share growth for next year|XTLB: Net earnings per share growth forecast for next year|BOLT (boltbio.com) - Expected earnings per share growth for next year|Expected earnings per share growth for next year HCW Biologics|APVO (Aptevo Therapeutics, Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year AIM|Projected earnings per share growth rate for next year Aditxt ADTX|Earnings growth forecast for next year GRI Bio Corporation (GRI)|XRTX: Expected net earnings per share growth next year|HIND - Expected earnings per share growth for next year|Revelation Biosciences, Inc. (REVB) - Projected earnings per share growth rate for next year|INDP (Indaptus Therapeutics Inc) - Projected earnings per share growth rate for next year|SCNI (Scinai) - Expected earnings per share growth for next year|CalciMedica - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Affimed NV|Allakos Therapeutics - Net earnings per share change forecast for next year|Earnings growth forecast for next year HOOK|IGMS (igmbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ITOS (iTeos)|Earnings growth forecast for next year Ocean Biomedical Corp OCEA|TCBP - Net earnings per share growth forecast for next year|Expected earnings per share trend next year THRD (thirdharmonicbio.com)
